The iPhonECG The iPhonECG uses a slim, low-power sleeve with a couple of electrodes on the back to provide clinical-quality cardiac event readings. You can either hold it in your hands to get a reading of your pulse, or place it on the patient’s chest. The sleeve can also work …
Read More »Diabetes In Control
Newsflash: FDA Declines Approval of Afrezza and Limits Acetaminophen in Prescription Drugs
The FDA has declined to approve the Afrezza inhaled insulin device pending further data, device maker MannKind announced. The whistle-sized inhaler was designed to administer mealtime doses of powdered insulin in metered, single-use cartridges but ran into problems with the FDA over a redesign. More studies requested. FDA limits amount …
Read More »Fact: Most People Want to Know the Risk of Getting Diabetes
Most People Want to Know the Risk of Getting Diabetes: Researchers from Tufts Medical Center led a study of more than 1,400 people to determine if people would be willing to pay for a new blood test that would indicate the chances of developing a disease but would not help …
Read More »Did You Know? Asian Americans Show Higher Diabetes Rates
Asian Americans Show Higher Diabetes Rates: Despite being thinner, Asian Americans are more likely than whites to have Type 2 diabetes and the problem is growing, a new study which included 230,500 U.S. adults, finds. Diabetes rates rose over time reaching 8% among Asian adults and 6% among whites. Genes …
Read More »Did You Know? Resistance May Increase Risk of CVD in Type 1 Diabetes
Resistance May Increase Risk of CVD in Type 1 Diabetes: The Coronary Artery Calcification in Type 1 Diabetes (CACTI) study assessed the role of insulin action on peripheral glucose utilization and nonesterified fatty acid (NEFA) suppression in predicting coronary artery calcification (CAC) in Type 1 diabetes. Compared to subjects without …
Read More »Why Don’t People Take Their Insulin as Prescribed?
Risk factors differed between Type 1 and Type 2 diabetic patients, with diet nonadherence more prominent in Type 1 diabetes and….
Read More »FDA Still Inconclusive about Lantus Cancer Risk
Eighteen months after starting a probe of potential cancer risks associated with insulin glargine (Lantus), the FDA still hasn’t decided whether the concern is justified….
Read More »Risk Factors Go Up when Folks Sit Down
Sitting around too much is associated with a worsening of several cardiometabolic risk factors, an analysis of NHANES data revealed….
Read More »Just Two Hours of TV Increases Risk of Death and CVD
People who spend two hours or more a day in front of a screen during their leisure time — primarily watching television — have more than double the risk of cardiovascular events over four years compared with those who spend less than two hours a day in front of a …
Read More »Only 7% of the 60 Million with Prediabetes Are Aware
Measuring glycated hemoglobin levels may be an appropriate means of catching patients with prediabetes.…
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.